$CERS

$2.50▲ +9.2% YTD

2 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

CP $2.50▲ +9.2%Nov 2, 2026 · ThinkSabio Blog

$CERS Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells…

SEC 13D/G

CERS - Cerus Corporation - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$2.78▲ 41.12%Aug 13, 2026 · ThinkSabio Blog

$CERS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CERS Cerus Corporation : $2.78 Sector: Healthcare | YTD: 🔼+ 41…